Endometrial cancer: open trials in Sweden

• NCT06340568

  A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

  Trial Treatment · Phase 3 · BioNTech SE

  Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Uppsala University Hospital, Uppsala

  Registry updated 2026-10-16

• NCT06952504

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Region Skane Skanes Universitetssjukhus, Lund · Uppsala University Hospital, Uppsala

  Registry updated 2026-10-13

• NCT06989112

  DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

  Trial Treatment · Phase 3 · AstraZeneca

  Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Uppsala University Hospital, Uppsala

  Registry updated 2026-10-13

• NCT05417594

  Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  Trial Treatment · Phase 1/2 · AstraZeneca

  Region Skane Skanes Universitetssjukhus, Lund · Karolinska Universitets Sjukhuset,Studie behandlingsavdelning, B08:09, Stockholm

  Registry updated 2026-10-05

• NCT07213609

  A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

  Trial Treatment · Phase 1/2 · GlaxoSmithKline

  Lund · Stockholm · Uppsala

  Registry updated 2026-09-16

• NCT07233811

  Day Care in Robotic Surgery Hysterectomy. Investigate Quality of Life and Safety With Same Day Discharge After Robotic Hysterectomy for Patients With Benign and Malignant Disease. A Multicenter Randomized Study With 3 Hospitals in Stockholm Sweden.

  Trial Treatment · Karolinska Institutet

  Södersjukhuset, Stockholm · Danderyd Hospital, Stockholm · Karolinska University Hospital, Stockholm

  Registry updated 2025-11-18

• NCT05855941

  Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

  Research · Region Västerbotten

  Centre for Gynecology and Obstetrics, Umea University Hospital, Umeå

  Registry updated 2024-12-16

• NCT05797831

  Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

  Trial Treatment · Phase 2/3 · Kartos Therapeutics, Inc.

  Linkoping University Hospital, Linköping · Karolinska University Hospital, Stockholm

  Registry updated 2024-05-02

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error